跳至主要内容
临床试验/NCT03915834
NCT03915834Unknown不适用

Biomarkers to Predict Hemorrhage and Outcomes After Endovascular Treatment in Patients With Acute Large Vessel Occlusion

Capital Medical University2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年4月16日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
2
主要终点
Hemorrhagic transformation

研究概览

简要总结

The main aim of the biomarkers to predict Hemorrhagic transformation(HT) after endovascular treatment in Acute Ischemic Stroke Patients.

The study has three main parts. During the first part, the investigators propose to conduct an enrollment of patients after thrombectomy in acute Ischemic Stroke and healthy controls. Serum biomarkers levels were analyzed (before and after) endovascular treatment patients and controls respectively.

During the second part, HT was evaluated and classified on cranial computed tomography and/or MRI post- treatment and was considered as symptomatic HT (sHT) if associated with neurological deterioration.

During the third part, the investigators aim to demonstrate the level of biomarkers can significant predict HT and outcomes in stroke patients undergoing revascularization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be 18 or older;
  • have a clinical diagnosis of acute ischemic stroke
  • a score of 6 or more points on the NIHSS(the National Institutes of Health Stroke Scale);
  • be scheduled to undergo intraarterial (IA) therapy for acute hemispheric stroke;
  • patients eligible for IV alteplase should receive IV alteplase;
  • Intracranial arterial occlusion of the distal intracranial carotid artery, middle (M1/M2) ,anterior (A1/A2) cerebral artery,vertebral artery,basilar artery or posterior cerebral artery,demonstrated with CTA, MRA or DSA;
  • begin intra-arterial therapy within 24 hours of symptom onset;
  • have provided informed consent.

排除标准

  • have any pre-existing illness resulting in a modified Rankin Scale Score of 3 or higher prior to the qualifying stroke;
  • patients with known infectious, inflammatory, or neoplastic diseases at the time of treatment and non-availability of blood samples;
  • are pregnant.

结局指标

主要结局

Hemorrhagic transformation

时间窗: 24 to 72 hours

Hemorrhagic transformation was diagnosed by Computed tomographic scans usually performed 24 to 72 hours after the procedure.Symptomatic intracranial hemorrhage was defined as neurologic deterioration (an increase of 4 or more points in the score on the NIHSS) and evidence of intracranial hemorrhage on imaging studies.

次要结局

  • Modified Rankin scale(90 days)

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Xunming,MD,PhD

Principal Investigator

Capital Medical University

研究点 (2)

Loading locations...

相似试验